28 day old flies expressing ApplScer\UAS.cCSa under the control of Scer\GAL4GMR.PU show some vacuoles in the lamina cortex.
Flies expressing ApplScer\UAS.cCSa under the control of Scer\GAL4elav.PU show a dramatic age-dependent decline in their performance index in a fast phototaxis assay.
30 day old flies expressing ApplScer\UAS.cCSa under the control of Scer\GAL4GMR.PF have dense aggregates in the retina (these aggregates are not seen in these flies at 1 or 5 days after eclosion or in wild-type controls). These aggregates have characteristics of amyloid deposits.
Expression of ApplScer\UAS.cCSa under the control of either Scer\GAL4elav-C155 or Scer\GAL4Appl.G1a results in the formation of deposits (that stain with toluidine blue) in the brains of aged flies, although the deposits are quite rare.
Vacuoles are seen in the retina of flies expressing ApplScer\UAS.cCSa under the control of Scer\GAL4GMR.PF; they are not seen in 1-2 day old flies, but by 10 days after eclosion, an increasing number of small vacuoles scattered throughout the retina are seen, and by 30 days after eclosion, the vacuoles have increased in size and number.
20 day old flies expressing ApplScer\UAS.cCSa under the control of Scer\GAL4elav-C155 have a significantly lower performance index in a fast phototaxis assay than young flies or age-matched control flies.
ApplUAS.cCSa, Scer\GAL4elav.PU has abnormal phototaxis | adult stage | progressive phenotype, suppressible by Bace5243/Bace[+]
ApplUAS.cCSa, Scer\GAL4GMR.PU is a non-enhancer of abnormal neuroanatomy | adult stage | progressive phenotype of BaceGD5366, Scer\GAL4GMR.PU
Scer\GAL4Appl.G1a/ApplUAS.cCSa is a suppressor | partially of abnormal neuroanatomy | third instar larval stage phenotype of Appld, SNF4Aγloe
Scer\GAL4elav-C155/ApplUAS.cCSa is a suppressor of abnormal neuroanatomy | adult stage phenotype of sws1
Scer\GAL4Appl.G1a/ApplUAS.cCSa is a suppressor of abnormal neuroanatomy | third instar larval stage phenotype of SNF4Aγloe
ApplUAS.cCSa, Scer\GAL4GMR.PU is a non-suppressor of abnormal neuroanatomy | adult stage | progressive phenotype of BaceGD5366, Scer\GAL4GMR.PU
ApplUAS.cCSa, Scer\GAL4Appl.G1a has adult brain phenotype, enhanceable by BaceUAS.cCSa, Scer\GAL4Appl.G1a
Scer\GAL4Appl.G1a/ApplUAS.cCSa is a suppressor | partially of larval brain | third instar larval stage phenotype of Appld, SNF4Aγloe
Scer\GAL4elav-C155/ApplUAS.cCSa is a suppressor of adult brain phenotype of sws1
Scer\GAL4Appl.G1a/ApplUAS.cCSa is a suppressor of larval brain | third instar larval stage phenotype of SNF4Aγloe
ApplUAS.cCSa, BaceGD5366, Scer\GAL4GMR.PU has lamina phenotype
ApplUAS.cCSa, BaceUAS.cCSa, Scer\GAL4Appl.G1a has adult brain phenotype
Co-expression of ApplScer\UAS.cCSa does not increase in general the lamina degeneration phenotype seen in 28 day old flies expressing BaceGD5366 under the control of Scer\GAL4GMR.PU, although vacuoles are occasionally seen in the lamina neuropil in these flies.
The age-dependent decline in performance index in a fast phototaxis assay of flies expressing ApplScer\UAS.cCSa under the control of Scer\GAL4elav.PU is suppressed if they are also heterozygous for Bace5243. The flies also show an increase in survival.
Expression of ApplScer\UAS.cCSa under the control of Scer\GAL4Appl.G1a substantially suppresses the increase in vacuolisation seen in the brains of SNF4Aγloe mutant third instar larvae.
Expression of ApplScer\UAS.cCSa under the control of Scer\GAL4Appl.G1a partially suppresses the vacuolisation seen in 4 day old Appld SNF4Aγloe double mutant males, returning the phenotype to the level seen in SNF4Aγloe single mutants.
Expression of ApplScer\UAS.cCSa under the control of Scer\GAL4elav-C155 fails to suppress the vacuolisation seen in the brains of sws1 mutant 14 day old males.
Co-expression of BaceScer\UAS.cCSa results in a marked increase in the amyloid deposits seen in flies expressing ApplScer\UAS.cCSa under the control of Scer\GAL4GMR.PF.
Co-expression of BaceScer\UAS.cCSa and ApplScer\UAS.cCSa under the control of Scer\GAL4Appl.G1a results in the formation of numerous toluidine blue-positive deposits in the brain. These flies also have spongiform lesions scattered throughout the brain.
20 day old flies co-expressing BaceScer\UAS.cCSa and ApplScer\UAS.cCSa under the control of Scer\GAL4Appl.G1a have fibrillar structures and dense bodies in the axons.